ロード中...
Variants in the ITPA Gene Protect Against Ribavirin-Induced Hemolytic Anemia and Decrease the Need for Ribavirin Dose Reduction
BACKGROUND & AIMS: In a genome-wide association study of patients being treated for chronic hepatitis C, 2 functional variants in ITPA that cause inosine triphosphatase (ITPase) deficiency were shown to protect against ribavirin (RBV)-induced hemolytic anemia during early stages of treatment. We...
保存先:
主要な著者: | , , , , , , , , , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
2010
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3086671/ https://ncbi.nlm.nih.gov/pubmed/20547162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2010.06.016 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|